MISSISSAUGA, ON, Nov. 12, 2014 /PRNewswire/ - KP Tissue Inc. ("KPT") (TSX: KPT) reports the Q3 2014 Financial and Operational Results of KPT and Kruger Products L.P. (KPLP): 

  • Revenue increased by 9.8% to $267.6 million in Q3 2014 compared to $243.8 million in Q3 2013
  • EBITDA of $38.0 million in Q3 2014, up from $31.1 million in Q3 2013
  • Maintained number one overall consumer market share in Canada

"We are pleased by our solid EBITDA performance of $38.0 million in the third quarter, an increase of over 22% compared to last year. The EBITDA increase primarily reflects higher sales volume in Canada and greater TAD Product contribution in the U.S.," said Mario Gosselin, CEO of KP Tissue and KPLP. 

"The recent Metro Paper acquisition also improved the results in the Away-from-Home (AFH) segment. TAD Products contributed $6.5 million during the third quarter and we have updated the expected EBITDA contribution for fiscal 2014 to between $23 million to $25 million, raising the bottom end of the range.

"Our EBITDA outlook for the fourth quarter is for year-over-year improvement. Compared to Q3 2014, we expect that Q4 EBITDA will be reduced due to seasonally higher advertising expenditures and plant maintenance costs," Mr. Gosselin concluded.

KP Tissue Inc.
KPT currently holds a 16.5% interest in KPLP. The highlights, discussion and analysis in this earnings release, unless identified specifically as representing the financial results of only KPT, relates entirely to the financial results of KPLP. 

KPLP Q3 2014 Financial Results
Revenue in Q3 2014 was $267.6 million, compared to $243.8 in Q3 2013, an increase of $23.8 million. Revenue increased across all segments and geographies and was primarily due to the acquisition of Metro Paper on June 3rd in the AFH segment.  Revenue also increased as a result of higher sales volume in the Consumer segment in Canada, an increase in TAD Product sales in the U.S., and the favourable impact of foreign exchange on U.S. dollar sales.

Cost of sales in Q3 2014 was $219.9 million, compared to $200.7 million in Q3 2013 due to increases in commodity prices, particularly pulp fibre and natural gas, the unfavourable impact of foreign exchange, and an increase in freight expenses related primarily to higher sales volume. These cost increases were offset somewhat by the favourable mix of products sold, cost reduction initiatives and timing of maintenance spending. As a percentage of revenue, cost of sales were 82.2 percent in Q3 2014 compared to 82.4 percent in Q3 2013.

Selling, general and administrative (SG&A) expenses in Q3 2014 were $17.7 million, compared to $19.7 million in Q3 2013 due to lower advertising and promotion expenses, partially offset by the impact of a realized loss on foreign exchange. 

EBITDA in Q3 2014 was $38.0 million compared to $31.1 million in Q3 2013, driven by favourable sales volume and mix resulting from increased sales in the Canadian Consumer business and in the U.S. for TAD Products and lower SG&A, as well as incremental EBITDA from the AFH Metro Paper acquisition. TAD Product EBITDA was $6.5 million in Q3 2014 compared to EBITDA of $1.8 million in Q3 2013.

Net income in Q3 2014 was $16.1 million, compared to $14.2 million in Q3 2013. The increase was primarily due to the increase in EBITDA of $6.9 million, partially offset by a change in the amortized cost of the Partnership unit liability of $1.1 million, an unrealized foreign exchange loss of $2.7 million and higher depreciation expense as a result of the TAD Project.

The cash balance as of September 28, 2014 was $36.3 million compared to $40.5 million as of June 29, 2014. Cash generated from operating activities resulting from EBITDA in Q3 2014 and a reduction in pension funding was more than offset by additional working capital requirements and interest and debt payments in the quarter.

KPT Q3 2014 Financial Results

  • Net income of $0.6 million in Q3 2014
  • Earnings per share of $0.08 in Q3 2014

Included in the net income of $0.6 million in Q3 2014 was $2.7 million representing KPT's share of KPLP's profit. The profit was offset somewhat by depreciation expense of $1.4 million related to adjustments to carrying amounts on acquisition, and income tax expense of $0.8 million. 

KPLP Distribution
KPLP will pay a distribution of $0.18 per KPLP unit to its partners on or prior to January 15, 2015.

Dividends on Common Shares
The Board of Directors of KP Tissue Inc. declared a quarterly dividend of $0.18 per share to be paid on January 15, 2015 to shareholders of record at the close of business on December 31, 2014.

Conference Call Information
KPT will hold its third quarter conference call on Wednesday, November 12, 2014 at 8:30 a.m. Eastern Time.

Details of conference call:
Via telephone:  1-888-231-8191 or 647-427-7450
Via the internet at: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

Conference Call Rebroadcast
A rebroadcast of the conference call will be available until midnight, December 12, 2014 by dialing 1-855-859-2056 or 416-849-0833 and entering passcode 2719340.

The replay of the webcast will remain available on the web site until midnight, December 12, 2014.

About KP Tissue Inc. (KPT)
KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP, which is accounted for as an investment on the equity basis. KPT currently holds a 16.5% interest in KPLP. For more information visit www.kptissueinc.com. 

About Kruger Products L.P. (KPLP)
KPLP is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPLP serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®' and White Swan®. In the U.S., KPLP manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPLP has approximately 2,500 employees across North America and operates five FSC® CoC- certified mills (FSC® C104904), four of which are located in Canada and one in the US. For more information visit www.krugerproducts.ca.

Non-IFRS Measures
This press release uses certain non-IFRS financial measures and ratios which KPLP believes provide useful information to both management of KPLP and the readers of the financial information in measuring the financial performance and financial condition of KPLP. These measures do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similarly titled measures presented by other companies. An example of such measures is EBITDA. EBITDA is not a measurement of operating performance computed in accordance with IFRS and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with IFRS. "EBITDA" is calculated by KPLP as net income (loss) before (i) interest expense, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) impairment of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) unrealized foreign exchange loss (gain), (viii) one-time costs related to restructuring activities, and (ix) change in the amortized cost of the Partnership unit liability. A reconciliation of EBITDA to the relevant reported results can be found in the Management's Discussion and Analysis ("MD&A") of KPT and KPLP for the third quarter ended September 28, 2014 available on SEDAR at www.sedar.com.

Forward-Looking Statements
Certain statements in this press release about KPT's and KPLP's current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking information is based on certain key expectations and assumptions made by KPT, including expectations and assumptions concerning the impact of the TAD Project on EBITDA. Although KPT believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information since no assurance can be given that such expectations and assumptions will prove to be correct.

Many factors could cause KPLP's actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from the Corporation's economic interest in KPLP) to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the "Risk Factors - Risks Related to KPLP's Business" section of the KPT Annual Information Form dated March 19, 2014 available on SEDAR at www.sedar.com: Kruger Inc.'s influence over KPLP; KPLP's reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the TAD Project; operational risks; Gatineau Plant land lease; significant increases in prices; reduction in supply of fibre; increased pricing pressure and intense competition; KPLP's inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of KPLP or KPLP's brands; KPLP's sales being less than anticipated; KPLP's failure to implement its business and operating strategies; KPLP's obligation to make regular capital expenditures; KPLP's entering into unsuccessful acquisitions; KPLP's dependence on key personnel; KPLP's inability to retain its existing customers or obtain new customers; KPLP's loss of key suppliers; KPLP's failure to adequately protect its intellectual property rights; KPLP's reliance on third party intellectual property licenses; adverse litigation and other claims affecting KPLP; material expenditures due to comprehensive environmental regulation affecting KPLP's cash flow; KPLP's pension obligations are significant and can be materially higher than predicted if KPLP Management's underlying assumptions are incorrect; labour disputes adversely affecting KPLP's cost structure and KPLP's ability to run its plants; exchange rate and U.S. competitors; KPLP's inability to service all of its indebtedness; exposure to potential consumer product liability, restrictive covenants; interest rate and refinancing risk; information technology and innovation; insurance; and internal controls.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Financial Position
(thousands of Canadian dollars)
 
  September 28, 2014
$
  December 31, 2013
$
Assets      
Current assets      
  Cash and cash equivalents 36,339   87,674
  Trade and other receivables 108,386   94,789
  Receivables from related parties 789   1,429
  Advances to partners 2,432   -
  Inventories 152,479   151,505
  Current portion of income tax recoverable 745   630
  Prepaid expenses 7,644   4,777
  308,814   340,804
Non-current assets      
  Property, plant & equipment 635,903   616,687
  Other long-term assets 9,621   10,268
  Income tax recoverable 15,078   14,132
  Goodwill 160,842   152,021
  Intangible assets 13,993   13,483
  Deferred income taxes 18,732   14,141
Total assets 1,162,983   1,161,536
       
Liabilities      
Current liabilities      
  Trade and other payables 159,236   188,470
  Payables to related parties 5,397   5,134
  Distributions payable 9,600   9,455
  Current portion of provisions 1,946   999
  Current portion of long-term debt 11,650   8,276
  187,829   212,334
Non-current liabilities      
  Long-term debt 354,941   342,013
  Other long-term liabilities 192   323
  Provisions 7,782   6,615
  Pensions 102,577   80,380
  Post-retirement benefits 53,312   48,746
  Liabilities to non-unitholders 706,633   690,411
  Current portion of Partnership units liability 3,475   3,475
  Long-term portion of Partnership units liability 116,796   114,364
  Total Partnership units liability 120,271   117,839
Total liabilities 826,904   808,250
       
Equity      
  Partnership units 295,422   282,672
  Retained earnings 8,270   50,945
  Accumulated other comprehensive income 32,387   19,669
Total equity 336,079   353,286
Total equity and liabilities 1,162,983   1,161,536


Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Comprehensive Income
(thousands of Canadian dollars)
               
 
 
 
 
13-week
period ended
September 28, 2014
$
 
 
 
 
13-week
period ended
September 29, 2013
$
 
 
 
 
39-week
period ended
September 28, 2014
$
 
 
 
 
39-week
period ended
September 29, 2013
$
               
Revenue 267,629   243,848   767,521   712,402
               
Expenses              
  Cost of sales 219,914   200,811   645,137   585,611
  Selling, general and administrative expenses 17,717   19,685   58,125   62,853
  Recovery of non-financial assets -   -   -   (1,789)
  Restructuring costs -   -   2,835   -
               
Operating income 29,998   23,352   61,424   65,727
               
  Interest expense 12,622   11,403   34,923   32,300
  Other (income) expense 2,752   (899)   7,622   1,824
               
Income before income taxes 14,624   12,848   18,879   31,603
               
Income taxes (1,477)   (1,315)   (2,118)   (9,653)
               
Net income for the period 16,101   14,163   20,997   41,256
               
Other comprehensive income (loss)              
  Items that will not be reclassified to net income:              
  Remeasurements of pensions (1,999)   8,580   (31,511)   42,278
  Remeasurements of post-retirement benefits (18)   5   (3,511)   1,509
  Items that may be subsequently reclassified to net income:              
  Available-for-sale investment (183)   78   (321)   78
  Cumulative translation adjustment 12,260   (5,506)   13,039   7,868
                 
Total other comprehensive income (loss) for the period 10,060   3,157   (22,304)   51,733
               
Comprehensive income (loss) for the period 26,161   17,320   (1,307)   92,989


Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Cash Flows
(thousands of Canadian dollars)
               
  13-week
period ended
September 28, 2014
$
  13-week
period ended
September 29, 2013
$
  39-week
period ended
September 28, 2014
$
  39-week
period ended
September 29, 2013
$
Cash flows from (used in) operating activities              
Net income for the period 16,101   14,163   20,997   41,256
Items not affecting cash              
  Depreciation 8,380   7,675   26,574   23,864
  Amortization 148   139   479   415
  Loss (gain) on sale of fixed assets (577)   -   (279)   (4)
  Change in amortized cost of Partnership units liability 1,043   -   5,907   -
  Unrealized foreign exchange loss 1,796   (927)   1,879   1,566
  Interest expense 12,622   11,403   34,923   32,300
  Pension and post retirement benefits 2,435   2,422   7,439   7,586
  Provisions 245   212   2,666   697
  Income taxes (1,477)   (1,315)   (2,118)   (9,653)
  Recovery of non-financial assets -   -   -   (1,789)
  Total items not affecting cash 24,615   19,609   77,470   54,982
               
Net change in non-cash working capital  (12,395)   (885)   (29,663)   (45,101)
Contributions to pension and post-retirement benefit plans (4,043)   (7,251)   (20,260)   (21,968)
Provisions paid (247)   (207)   (1,084)   (2,009)
Income tax payments (736)   (382)   (1,622)   (2,119)
Net cash from (used in) operating activities 23,295   25,047   45,838   25,041
               
Cash flows from (used in) investing activities              
Purchase of property, plant & equipment (6,628)   (3,964)   (19,994)   (11,554)
Purchases of through-air-dried (TAD) expansion (978)   (4,294)   (7,190)   (33,067)
Available-for-sale investment -   (836)   -   (836)
Government grants received -   1,078   -   1,078
Purchases of software (221)   (3)   (989)   (93)
Proceeds on sale of property, plant and equipment 577   -   578   4
Acqusition of business (net) -   -   (23,360)   -
Net cash used in investing activities (7,250)   (8,019)   (50,955)   (44,468)
Cash flows from (used in) financing activities              
Proceeds from credit facilities -   6,242   -   10,813
Repayment of credit facilities (3,824)   (366)   (4,334)   (4,096)
Payment of deferred financing fees -   (159)   -   (612)
Interest paid on credit facilities (10,799)   (7,210)   (21,196)   (21,181)
Distributions and advances (10,592)   (9,367)   (34,287)   (20,599)
Equity issuance costs -   (1,206)   -   (1,206)
Proceeds from issuing partnership units 4,284   4,897   12,750   22,280
Net cash used in financing activities (20,931)   (7,169)   (47,067)   (14,601)
Effect of exchange rate changes on cash and cash equivalents held in foreign currency 741   (409)   849   353
Decrease in cash and cash equivalents during the period (4,145)   9,450   (51,335)   (33,675)
Cash and cash equivalents - Beginning of period 40,484   78,364   87,674   121,489
Cash and cash equivalents - End of period 36,339   87,814   36,339   87,814


Kruger Products L.P.
Segment and Geographic Results
(thousands of Canadian dollars)
               
 
 
 
 
13-week
period ended
September 28, 2014
$
 
 
 
 
13-week
period ended
September 29, 2013
$
 
 
 
 
39-week
period ended
September 28, 2014
$
 
 
 
 
39-week
period ended
September 29, 2013
$
               
Segment Information              
               
Segment Revenue              
  Consumer 209,495   200,802   624,773   590,563
  AFH 52,613   40,321   130,359   115,606
  Other 5,521   2,725   12,389   6,233
Total segment revenue 267,629   243,848   767,521   712,402
               
Segment EBITDA              
  Consumer 37,745   30,087   92,235   83,116
  AFH 1,767   1,193   1,380   5,333
  Other (1,476)   (142)   (2,418)   (494)
Total segment EBITDA 38,036   31,138   91,197   87,955
               
Reconciliation to Net Income:              
Depreciation and amortization 8,528   7,814   27,053   24,279
Interest expense 12,622   11,403   34,923   32,300
Change in amortized cost of Partnership units liability 1,043   -   5,907   -
Gain (loss) on sale of fixed assets (577)   -   (279)   (4)
Recovery of non-financial assets -   -   -   (1,789)
Restructuring costs -   -   2,835   -
Unrealized foreign exchange loss 1,796   (927)   1,879   1,566
Income before income taxes 14,624   12,848   18,879   31,603
Income taxes (1,477)   (1,315)   (2,118)   (9,653)
Net income for the period 16,101   14,163   20,997   41,256
               
Geographic Revenue              
Canada 182,260   175,290   516,401   515,939
U.S. 77,758   62,170   230,826   175,635
Mexico 7,611   6,388   20,294   20,828
Total Revenue 267,629   243,848   767,521   712,402


KP Tissue Inc.
Unaudited Condensed Statement of Financial Position
(thousands of Canadian dollars)
       
 
 
September 28, 2014
$
 
 
December 31, 2013
$
Assets      
       
Current assets      
  Distributions receivable 1,593   1,583
  Receivable from Partnership 127   -
  1,720   1,583
Non-current assets      
  Investment in associate 153,206   161,584
Total Assets 154,926   163,167
       
Liabilities      
       
Current liabilities      
  Dividend payable 1,593   1,583
  Payables to Partnership 153   -
  Advances from Partnership 409   -
  Income taxes payable 433   580
  2,588   2,163
Non-current liabilities      
  Deferred income taxes 2,030   3,033
       
Total liabilities 4,618   5,196
       
Equity      
       
  Common shares 9,945   9,068
  Contributed surplus 144,819   144,819
  Retained earnings (deficit) (10,245)   709
  Accumulated other comprehensive income 5,789   3,375
Total equity 150,308   157,971
Total liabilities and equity 154,926   163,167


KP Tissue Inc.
Unaudited Condensed Statement of Comprehensive Income
(thousands of Canadian dollars, except share and per share amounts)
               
  13-week
period ended
September 28, 2014
$
  13-week
period ended
September 29, 2013
$
  39-week
period ended
September 28, 2014
$
  39-week
period ended
September 29, 2013
$
               
Equity income (loss) 1,235   1,016   (944)   1,497
               
Gain on remeasurement of over allotment option -   -   -   375
Dilution gain 37   69   95   181
Loss before income taxes 1,272   1,085   (849)   2,053
               
Income tax expense (recovery)              
Current 791   293   872   892
Deferred (206)   277   (454)   737
  585   570   418   1,629
Net income (loss) for the period 687   515   (1,267)   424
               
Other comprehensive income (loss)              
  Items that will not be reclassified to net loss:              
  Remeasurements of pensions - net of tax recovery (284)   1,254   (4,564)   6,186
  Remeasurements of post-retirement benefits - net of tax recovery (1)   1   (356)   221
  Items that may be subsequently reclassified to net loss:              
  Available-for-sale investment - net of tax recovery (26)   -   (47)   -
  Cumulative translation adjustment - net of tax expense 2,309   (807)   2,461   1,150
Total other comprehensive income (loss) for the period 1,998   448   (2,506)   7,557
Comprehensive income (loss) for the period 2,685   963   (3,773)   7,981
Basic earnings (loss) per share 0.08   0.06   (0.14)   0.05
Weighted average number of shares outstanding 8,845,503   8,781,433   8,825,759   8,739,702


KP Tissue Inc.
Unaudited Condensed Statement of Cash Flows
(thousands of Canadian dollars)
               
  13-week
period ended
September 28, 2014
$
  13-week
period ended
September 29, 2013
$
  39-week
period ended
September 28, 2014
$
  39-week
period ended
September 29, 2013
$
Cash flows from (used in) operating activities              
Net income (loss) for the period 687   515   (1,267)   424
Items not affecting cash              
  Equity loss (income) (1,235)   (1,016)   944   (1,497)
  Gain on remeasurement of overallotment option -   -   -   (375)
  Dilution gain (37)   (69)   (95)   (181)
  Income taxes 585   570   418   1,629
  Total items not affecting cash (687)   (515)   1,267   (424)
Income tax payments (175)   -   (868)   -
Net cash from (used in) operating activities (175)   -   (868)   -
               
Cash flows from (used in) investing activites              
Investment in associate (303)   (150)   (877)   (13,719)
Partnership unit distributions received 1,589   1,579   4,757   3,477
Tax distributions received -   -   459   -
Advances received 175   -   409   -
Net cash from (used in) investing activities 1,461   1,429   4,748   (10,242)
               
Cash flows from (used in) financing activities              
Issuance of common shares 303   150   877   13,719
Dividends paid (1,589)   (1,579)   (4,757)   (3,477)
Net cash from (used in) financing activities (1,286)   (1,429)   (3,880)   10,242
Increase (decrease) in cash and cash equivalents during the period -   -   -   -
Cash and cash equivalents - Beginning of period -   -   -   -
Cash and cash equivalents - End of period -   -   -   -

 

 

 

SOURCE KP Tissue Inc.

Copyright 2014 PR Newswire

KP Tissue (TSX:KPT)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more KP Tissue Charts.
KP Tissue (TSX:KPT)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more KP Tissue Charts.